Bristol Myers Squibb has expanded its push into radiopharmaceuticals by licensing a prostate cancer therapy developed by Swiss biotech Philochem in a deal that includes an upfront payment of $350 ...
Gay (back) was limited at Thursday's practice. Gay missed the final session of Week 8 prep due to a back injury and then was ruled out ahead of Monday's eventual loss at Kansas City. Matthew Wright ...
Technology isn’t the biggest challenge. Culture is. by Tim Fountaine, Brian McCarthy and Tamim Saleh Artificial intelligence is reshaping business—though not at the blistering pace many assume. True, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback